TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6/13/23 16:44 | 6/10/23 | NVAX | Novavax Inc | MA | Health | BioPrd | Biological Products, (No Diag | Douglas Richard | MD | D | M.d | 0 | 0.00 | 0 | 3 | 9 | 37 | D | |||||||||||||||
3/30/23 09:11 | 3/29/23 | MXCT | Maxcyte, Inc. | MA | Health | BioPrd | Biological Products, (No Diag | Douglas Richard | MD | D | P | 345 | 4.32 | 0 | 80 | 400 | 100 | D | |||||||||||||||
6/21/22 20:46 | 6/17/22 | NVAX | Novavax Inc | MA | Health | BioPrd | Biological Products, (No Diag | Douglas Richard | MD | D | M.d | 0 | 0.00 | 0 | 1 | 2 | 34 | D | |||||||||||||||
12/15/21 17:22 | 12/13/21 | NVAX | Novavax Inc | MA | Health | BioPrd | Biological Products, (No Diag | Douglas Richard | MD | D | M.d | 38 | 25.60 | 0 | 2 | 5 | 33 | D | |||||||||||||||
11/23/21 07:46 | 11/22/21 | MXCT | Maxcyte, Inc. | MA | Health | BioPrd | Biological Products, (No Diag | Douglas Richard | MD | D | P | 222 | 11.12 | 0 | 20 | New | 20 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |